SUSAN NEWELL: Open Payments
NPI 1376107409 · MANTACHIE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $315 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Corcept Therapeutics | 3 | $59 |
| Lilly USA, LLC | 2 | $36 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| CeQur Corporation | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: TWIIST, FARXIGA, Korlym, MOUNJARO, NEXLETOL, CeQur Simplicity, VRAYLAR, EVENITY.
Industry payments across MS — which companies pay providers there.
